Adapalene Completed Phase 4 Trials for Acne Vulgaris Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00660985Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%
NCT01188538Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel
NCT03626298Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia
NCT00160394Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris
NCT00469755Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne
NCT00658112Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne
NCT00671749Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris
NCT00696449Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris
NCT00714714Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face.
NCT00757523Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris
NCT00807014Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
NCT00887484A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne
NCT00919191Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face
NCT00926367Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications
NCT00952523Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face
NCT00964223A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne
NCT01149330Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
NCT01209949Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
NCT01231334A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne
NCT01387048Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin
NCT01504204Effect of Samples on Acne Treatment With Epiduo® Gel
NCT01522456Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel
NCT02249104A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris
NCT02721173Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris
NCT02731105Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products
NCT02899000A Treatment for Severe Inflammatory Acne Subjects